Publications & Resources

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

To support policyholders as they navigate the pandemic, MLMIC has assembled a summary of predictive tools and technology to guide management and treatment of COVID-19.

MLMIC encourages policyholders to review attorneys’ answers to frequently asked questions on medical professional liability related to hospital related issues, including addendums to the medical record and use of nurse practitioners.

Improved treatment of COVID-19 is reducing mortality rates among those hospitalized for the infection, but experts caution the virus remains dangerous.

A recent settlement issued by the Office for Civil Rights highlights the importance of adhering to HIPAA’s Right of Access Initiative, a directive requiring covered entities to provide patients, upon request, with timely access to their protected health information.

Healthcare professionals share in the responsibility for minimizing prescription drug abuse and drug diversion. Physicians are tasked with differentiating patients in need of effective pain management from those who may be seeking drugs for inappropriate reasons. Review this Risk Management Tip from MLMIC to reinforce related policies and protocols within your practice or facility.

Federal agencies warn of a spike in ransomware targeting hospitals and other healthcare organizations, and at least one health system in New York – St. Lawrence Health System – has reported an attack during this recent burst of cybercrimes.

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.

Based on a series of patient testimonials, the National Institute for Health Research says that ‘long COVID’ could actually be up to four different syndromes.

As use of telehealth continues to grow, physicians are advised to consider key factors when determining whether a virtual visit is the best option for a patient.